tbuckley/cabot-search huggingface dataset:
Healing Without Waging War: Beyond Military Metaphors in Medicine and HIV Cure Research
Authors: Jing-Bao Nie, Adam Gilbertson, Malcolm de Roubaix, Ciara Staunton, Anton van Niekerk, Joseph D. Tucker, Stuart Rennie
Journal: The American Journal of Bioethics (2016)

Military metaphors are pervasive in biomedicine, including HIV research. Rooted in the mind set that regards pathogens as enemies to be defeated, terms such as "shock and kill" have become widely accepted idioms within HIV cure research. Such language and symbolism must be critically examined as they may be especially problematic when used to express scientific ideas within emerging health-related fields. In this article, philosophical analysis and an interdisciplinary literature review utilizing key texts from sociology, anthropology, history, and Chinese and African studies were conducted to investigate the current proliferation of military metaphors. We found the use of these metaphors to be ironic, unfortunate, and unnecessary. To overcome military metaphors we propose to (1) give them less aggressive meanings, and/or (2) replace them with more peaceful metaphors. Building on previous authors' work, we argue for the increased use of "journey" (and related) metaphors as meaningful, cross-culturally appropriate alternatives to military metaphors.
A bilateral macular star and optic disc oedema
Authors: Inês Leal, David Cordeiro Sousa
Journal: BMJ (2016)

A 25 year old African man presented with reduced vision and headache lasting three hours. His blood pressure was 228/132 mm Hg (normal: <140/90 mm Hg1). Best corrected visual acuity was 20/80 in the right eye and 20/120 in the left eye (normal: 20/20). The figure shows the fundus of the right eye (fig 1).



Fig 1 
Colour fundus photography of right eye, …
Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis
Authors: Shaoxuan Hu, Xiaohui He, Yuankai Shi, Sheng Yang, Yan Qin, Jianliang Yang, Mei Dong, Shengyu Zhou, Peng Liu, Lin Gui, Changgong Zhang, Liqiang Zhou
Journal: Blood (2015)
IL-4RA Signaling Regulates Liver Fibrosis Progression and Reversal Differently by Modulating Polarization of M2 Macrophage Subsets
Authors: S.Y. Weng, S. Vijayan, X. Wang, Y. Tang, K. Padberg, Y.O. Kim, F. Brombacher, J. Crosby, M. McCaleb, A. Waisman, E. Bockamp, D. Schuppan
Journal: Journal of Hepatology (2016)
Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study
Authors: L. Kondili, M.G. Quaranta, L. Falzano, M. Di Gregorio, M. Brunetto, A.L. Zignego, A. Ciancio, A. Di Leo, M. Rendina, G. Raimondo, C. Ferrari, A. Craxì, G. Taliani, G. Borgia, I. Gentile, T.A. Santantonio, A. Giammario, P. Blanc, G.B. Gaeta, A. Gasbarrini, M. Siciliano, L. Chessa, E.M. Erne, D. Ieluzzi, F.P. Russo, P. Andreone, M. Vinci, C. Coppola, L. Chemello, S. Madonia, G. Verucchi, M. Persico, M. Zuin, A. Alberti, M. Puoti, G. Nardone, V. De Maria, M. Massari, G. Montalto, G. Foti, M.G. Rumi, A. Giacometti, A. Benedetti, G. D’Offizi, M. Strazzabosco, S. Fargion, G. Angarano, A. Federico, N. Caporaso, C. Mastroianni, P. Toniutto, M. Colombo, A. Lazzarin, C. Torti, M. Andreoni, F. Rosina, C. Viscoli, S. Vella, E. Villa
Journal: Journal of Hepatology (2016)
P1071 : The association between serum levels of uric acid and alanine aminotransferase in a population-based cohort
Authors: L. Rabinowich, O. Ben-Assuli, M. Green, A. Goldstein, A. Magid, V. Shalev, O. Shibolet, G. Chodick, S. Zelber-Sagi
Journal: Journal of Hepatology (2015)
The spindle assembly checkpoint in the induction of apoptosis by KSP inhibitors
Authors: Weikang Tao, Vicki South, Yun Zhang, Joe Davide, Nancy Kohl, Laura Sepp-Lorenzino, Rob Lobell
Journal: Cancer Research (2005)

2278  KSP, a mitotic kinesin that is essential for the formation of bipolar spindles during mitosis, has been considered as a novel target for cancer therapeutics and KSP inhibitors have entered clinical trials. The inhibition of KSP causes mitotic arrest by engaging the spindle assembly checkpoint, a signaling pathway with multiple components including Bub1 and Mad2, that monitors the proper attachment of microtubules to kinetochores and the tension between the kinetochores of sister chromatids to ensure faithful separation of chromosomes during mitosis. Using a potent and specific small molecule inhibitor of KSP, we have investigated the role of the spindle checkpoint in the induction of cell death by the inhibition of KSP. A HeLa-derived cell line was generated, where the spindle checkpoint can be suppressed by inducible expression of a dominant negative mutant of Bub1 (DN-Bub1). While the expression of DN-Bub1 did not affect the cell cycle progression or cell viability in the absence of spindle inhibitors, it impaired the spindle checkpoint function and attenuated KSP inhibitor-induced apoptosis. Additionally, Mad2 heterozygous HCT116 cells, that were defective in the spindle checkpoint due to Mad2 haplo-insufficiency, incurred less apoptosis than the Mad2 homozygous and checkpoint-proficient counterparts in response to KSP inhibition. The reduced sensitivity to KSP inhibitor in checkpoint-deficient cells was further confirmed using a 10-day colony formation assay and in additional cell lines. Together, our data indicate that a functional mitotic checkpoint is required for the induction of apoptosis by KSP antagonists.
Correlations between Hepatic Morphometric Collagen Content, Histologic Fibrosis Stage, and Serum Markers in Patients with Primary Sclerosing Cholangitis (PSC)
Authors: Z. Goodman, K. Patel, I. Guha, B. Hameed, K. Kowdley, L. Alaparthi, F. Monge, R.P. Myers, R. Aguilar, G.M. Subramanian, J.G. McHutchison, C.L. Bowlus, C. Levy, M. Manns, R. Chapman, A.J. Muir
Journal: Journal of Hepatology (2016)
Melatonin Mitigates the Nutritional and Morphological Changes of Rat Tongue with Secondary Biliary Cirrhosis Induced by Ligation of the Common Bile Duct
Authors: N.A.P. Marroni, J.R. Colares, E.G. Schemitt, R.M. Hartmann, F. Licks, M. Do Couto Soares, S. Fernandes, C.A. Marroni
Journal: Journal of Hepatology (2016)
Case 29-2016
Authors: Katherine T. Johnston, Pragya A. Dang, Michelle C. Specht, Alyssa R. Letourneau, Thomas M. Gudewicz
Journal: New England Journal of Medicine (2016)

A 53-year-old woman with systemic lupus erythematosus presented with pain and a lump in the left breast that had persisted for 5 days. Four months earlier, she had noted a smaller lump in a different location of the left breast. A diagnostic procedure was performed.
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
Authors: Etienne Puymirat, Elisabeth Riant, Nadia Aissoui, Angèle Soria, Gregory Ducrocq, Pierre Coste, Yves Cottin, Jean François Aupetit, Eric Bonnefoy, Didier Blanchard, Simon Cattan, Gabriel Steg, François Schiele, Jean Ferrières, Yves Juillière, Tabassome Simon, Nicolas Danchin
Journal: BMJ (2016)

<b>Objective</b>&nbsp;To assess the association between early and prolonged β blocker treatment and mortality after acute myocardial infarction. <b>Design</b>&nbsp;Multicentre prospective cohort study. <b>Setting</b>&nbsp;Nationwide French registry of Acute ST- and non-ST-elevation Myocardial Infarction (FAST-MI) (at 223 centres) at the end of 2005. <b>Participants</b>&nbsp;2679 consecutive patients with acute myocardial infarction and without heart failure or left ventricular dysfunction. <b>Main outcome measures</b>&nbsp;Mortality was assessed at 30 days in relation to early use of β blockers (≤48 hours of admission), at one year in relation to discharge prescription, and at five years in relation to one year use. <b>Results</b>&nbsp;β blockers were used early in 77% (2050/2679) of patients, were prescribed at discharge in 80% (1783/2217), and were still being used in 89% (1230/1383) of those alive at one year. Thirty day mortality was lower in patients taking early β blockers (adjusted hazard ratio 0.46, 95% confidence interval 0.26 to 0.82), whereas the hazard ratio for one year mortality associated with β blockers at discharge was 0.77 (0.46 to 1.30). Persistence of β blockers at one year was not associated with lower five year mortality (hazard ratio 1.19, 0.65 to 2.18). In contrast, five year mortality was lower in patients continuing statins at one year (hazard ratio 0.42, 0.25 to 0.72) compared with those discontinuing statins. Propensity score and sensitivity analyses showed consistent results. <b>Conclusions</b>&nbsp;Early β blocker use was associated with reduced 30 day mortality in patients with acute myocardial infarction, and discontinuation of β blockers at one year was not associated with higher five year mortality. These findings question the utility of prolonged β blocker treatment after acute myocardial infarction in patients without heart failure or left ventricular dysfunction. <b>Trial registration</b>&nbsp;Clinical trials NCT00673036.
Genome-Wide High-Throughput Screening Unveil Biomarkers Correlated with Galunisertib (LY2157299) Effectiveness in Hepatocellular Carcinoma
Authors: Y. Cao, R. Agarwal, F. Dituri, B. Rani, L. Lupo, P. Winter, G. Giannelli
Journal: Journal of Hepatology (2016)
Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: results from a double-blinded, placebo-controlled, crossover study
Authors: S. Grether-Beck, A. Marini, T. Jaenicke, W. Stahl, J. Krutmann
Journal: British Journal of Dermatology (2016)

Increasing evidence suggests photoprotection by oral supplementation with β‐carotene and lycopene. To examine the capacity of lycopene‐rich tomato nutrient complex (TNC) and lutein, to protect against ultraviolet (UV)A/B and UVA1 radiation at a molecular level. In a placebo‐controlled, double‐blinded, randomized, crossover study two active treatments containing either TNC or lutein were assessed for their capacity to decrease the expression of UVA1 the radiation‐inducible genes HO1, ICAM1 and MMP1. Sixty‐five healthy volunteers were allocated to four treatment groups and subjected to a 2‐week washout phase, followed by two 12‐week treatment phases separated by another 2 weeks of washout. Volunteers started either with active treatment and were then switched to placebo, or vice versa. At the beginning and at the end of each treatment phase skin was irradiated and 24 h later biopsies were taken from untreated, UVA/B‐ and UVA1‐irradiated skin for subsequent reverse transcriptase polymerase chain reaction analysis of gene expression. Moreover, blood samples were taken after the washout and the treatment phases for assessment of carotenoids. TNC completely inhibited UVA1‐ and UVA/B‐induced upregulation of heme‐oxygenase 1, intercellular adhesion molecule 1 and matrix metallopeptidase 1 mRNA, no matter the sequence (anova, P < 0·05). In contrast, lutein provided complete protection if it was taken in the first period but showed significantly smaller effects in the second sequence compared with TNC. Assuming the role of these genes as indicators of oxidative stress, photodermatoses and photoageing, these results might indicate that TNC and lutein could protect against solar radiation‐induced health damage.
Erlotinib Antagonizes Efflux Via ABC Transporters and Decreases P-Gp Cell Surface Expression by Inhibiting SRC Kinase and mTOR Pathways in Acute Myeloid Leukemia (AML)
Authors: Elodie Lainey, Marie Sebert, Cyrielle Bouteloup, Carole Leroy, Sylvain Thepot, Maximilien Tailler, Lionel Ades, Claude Gardin, Guido Kroemer, Pierre Fenaux, Simone Boehrer
Journal: Blood (2011)
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis
Authors: Salvatore Piano, Marta Tonon, Elia Vettore, Marialuisa Stanco, Chiara Pilutti, Antonietta Romano, Sara Mareso, Carmine Gambino, Alessandra Brocca, Antonietta Sticca, Silvano Fasolato, Paolo Angeli
Journal: Journal of Hepatology (2017)
Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia
Authors: Jamshid S Khorashad, Srinivas K Tantravahi, Dongqing Yan, Anna M. Eiring, Hannah M. Redwine, Amber D. Bowler, Kevin C. Gantz, Keith M Gligorich, Anthony D Pomicter, Todd W Kelley, Thomas O'Hare, Michael W Deininger
Journal: Blood (2015)
Assessment of Two Doses of Infliximab in Patients with Low/Intermediate Risk IPSS Myelodysplastic Syndrome (MDS): An EORTC Leukemia Group (LG) Randomized Phase II Trial (06023).
Authors: Liliana Baila, Stefan Suciu, Petra Muus, Sergio Amadori, Michel Delforge, Gert Ossenkoppele, Dominik L.D. Selleslag, Antoine Thyss, Hilde Demuynk, Alain Gadisseur, P. Vermeulen, Carla De Boer, Heinz Zwierzina, T.M. de Witte
Journal: Blood (2007)
4 risk assessment models had good calibration but poor discrimination for VTE in hospitalized medical patients
Authors: Aaron Liew, James Douketis
Journal: Annals of Internal Medicine (2016)

Source Citation Greene MT, Spyropoulos AC, Chopra V, et al. Validation of risk assessment models of venous thromboembolism in hospitalized medical patients. Am J Med. 2016 Apr 20. [Epub ahead of print]. 27107925
Abciximab (Reopro) Achieves Effective Platelet Inhibition in St-Elevation MI: A TIMI 14 Substudy
Authors: SA Coulter, CP Cannon, Frans Van de Werf, AA Adgey, J Scherer, A Machelli, ES Barnathan, KA Ault, RP Giugliano, CH McCabe, EM Antman, N Kleiman
Journal: Circulation (1998)
Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with a Lower Meld, less Inflammation and an Improved Survival
Authors: A.Q. Bhutta, G. Garcia-Tsao, R. Reddy, P. Tandon, F. Wong, J.G. O’Leary, C. Acharya, D. Banerjee, J.G. Abraldes, I. Plener, T.M. Jones, J. Shaw, Y. Deng, M. Ciarleglio, J.S. Bajaj
Journal: Journal of Hepatology (2016)
S93 Pulmonary Matrix Metalloproteinases and Small Airways Disease in COPD – The Origins of Airflow Obstruction?: Abstract S93 Table 1
Authors: K Ostridge, N Williams, V Kim, M Bennett, S Harden, L Welch, S Bourne, N Coombs, P Elkington, K Staples, T Wilkinson
Journal: Thorax (2015)

<h3>Introduction and objectives</h3> Matrix-metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extra-cellular matrix (ECM) and drive tissue remodelling, key processes in the pathogenesis of COPD. The development of small airway disease and emphysema have been identified as critical mechanisms in the development of airflow obstruction but the contribution of MMPs in human disease is poorly characterised. We investigated the role of MMPs in the lung by quantifying levels and determining relationships with the key pathological components of COPD, measured by CT, in patients and healthy controls. <h3>Methods</h3> 24 mild and moderate COPD and 8 control subjects were enrolled onto the study and underwent bronchoalveolar lavage (BAL) and high resolution CT. We analysed levels of MMPs in BAL using a Luminex immunoassay. Image analysis, performed using VIDA Apollo software, quantitatively assessed emphysema, bronchial wall thickening and small airways disease. <h3>Results</h3> Multiple MMPs (MMP-1, -2, -3, -8, -9 and -10) were significantly elevated in the lungs of COPD subjects. MMP -3, -7, -8, -9, -10, and -12 concentrations were closely associated with CT markers of small airways disease (Table 1). Emphysema severity was also associated with MMP-3, -7, -8 and -10. However there were no strong relationships between MMPs and bronchial wall thickness of the larger airways. Stepwise linear regression analysis identified MMP-10 to be the only significant predictor of emphysema (R<sup>2</sup> 0.34, p 0.001) that was independent of each of the other MMPs while MMP-8 was the only significant predictor of small airways disease (R<sup>2</sup> 0.56, p &lt; 0.001) independent of each of the other MMPs. <h3>Conclusion</h3> Pulmonary MMP concentrations are directly associated with the extent of gas trapping and small airways disease identified on CT scan. This suggests that MMPs may play a significant role in the pathogenesis of COPD by causing breakdown of the pulmonary ECM leading to abnormal remodelling in both the small airways and lung parenchyma. Whilst most previous work has focused on MMPs and emphysema, this study shows the strongest associations were with small airways disease.
Effectiveness of Simeprevir-Containing Regimens among Patients with Chronic Hepatitis C Virus in Various Us Practice Settings: The Sonet Study
Authors: I. Alam, K. Brown, C. Donovan, J. Forlenza, K. Lauwers, M.A. Mah’moud, R. Manch, S.R. Mohanty, A. Prabhakar, R. Reindollar, G. Sawyerr, J. Slim, N. Tandon, S. Villadiego, S. Naggie
Journal: Journal of Hepatology (2016)
Egr-1 Identifies Neointimal Remodeling In Pulmonary Arterial Hypertension Patients
Authors: van der Diederik Feen, M. G. Dickinson, B. Bartelds, M. A. J. Borgdirff, H. Sietsma, M. Levy, Rudolphus Berger
Journal: American Journal of Respiratory and Critical Care Medicine (2015)
All-Oral Treatment with Daclatasvir Plus Sofosbuvir ± Ribavirin in HCV Genotype 3-Infected Patients with Advanced Fibrosis or Cirrhosis: An Analysis of Ally-3 and Ally-3+
Authors: K. Kowdley, P. Angus, D. Bernstein, J.-P. Bronowicki, V. Leroy, P. Pockros, R. Bhore, K. Rana, M.J. Jimenez-Exposito
Journal: Journal of Hepatology (2016)
Identification of a New Inborn Error in the Peroxisomal Steps of Bile Acid Synthesis Resulting in Accumulation of Toxic Bile Acid Intermediates and Hepatocellular Damage
Authors: M.J. Monte, M. Alonso, O. Briz, E. Herraez, R.R. Macias, M.J. Perez, E. Lozano, R. Al-Abdulla, M. Asensio, F.G.-S. Martin, S. Jimenez, B. Castaño, J. Argemi, J. Prieto, J.J. Marin
Journal: Journal of Hepatology (2016)
Erratum: Corrigendum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Authors: Carl A Anderson, Gabrielle Boucher, Charlie W Lees, Andre Franke, Mauro D'Amato, Kent D Taylor, James C Lee, Philippe Goyette, Marcin Imielinski, Anna Latiano, Caroline Lagacé, Regan Scott, Leila Amininejad, Suzannah Bumpstead, Leonard Baidoo, Robert N Baldassano, Murray Barclay, Theodore M Bayless, Stephan Brand, Carsten Büning, Jean-Frédéric Colombel, Lee A Denson, Martine De Vos, Marla Dubinsky, Cathryn Edwards, David Ellinghaus, Rudolf S N Fehrmann, James A B Floyd, Timothy Florin, Denis Franchimont, Lude Franke, Michel Georges, Jürgen Glas, Nicole L Glazer, Stephen L Guthery, Talin Haritunians, Nicholas K Hayward, Jean-Pierre Hugot, Gilles Jobin, Debby Laukens, Ian Lawrance, Marc Lémann, Arie Levine, Cecile Libioulle, Edouard Louis, Dermot P McGovern, Monica Milla, Grant W Montgomery, Katherine I Morley, Craig Mowat, Aylwin Ng, William Newman, Roel A Ophoff, Laura Papi, Orazio Palmieri, Laurent Peyrin-Biroulet, Julián Panés, Anne Phillips, Natalie J Prescott, Deborah D Proctor, Rebecca Roberts, Richard Russell, Paul Rutgeerts, Jeremy Sanderson, Miquel Sans, Philip Schumm, Frank Seibold, Yashoda Sharma, Lisa A Simms, Mark Seielstad, A Hillary Steinhart, Stephan R Targan, Leonard H van den Berg, Morten Vatn, Hein Verspaget, Thomas Walters, Cisca Wijmenga, David C Wilson, Harm-Jan Westra, Ramnik J Xavier, Zhen Z Zhao, Cyriel Y Ponsioen, Vibeke Andersen, Leif Torkvist, Maria Gazouli, Nicholas P Anagnou, Tom H Karlsen, Limas Kupcinskas, Jurgita Sventoraityte, John C Mansfield, Subra Kugathasan, Mark S Silverberg, Jonas Halfvarson, Jerome I Rotter, Christopher G Mathew, Anne M Griffiths, Richard Gearry, Tariq Ahmad, Steven R Brant, Mathias Chamaillard, Jack Satsangi, Judy H Cho, Stefan Schreiber, Mark J Daly, Jeffrey C Barrett, Miles Parkes, Vito Annese, Hakon Hakonarson, Graham Radford-Smith, Richard H Duerr, Séverine Vermeire, Rinse K Weersma, John D Rioux
Journal: Nature Genetics (2011)
Iron Chelation Reinforces DNA Damage Response and Leads to G2/M Checkpoint Activation and Autophagy in Myeloid Bone Marrow Cells of Preleukemia Mouse Model
Authors: Leona Raskova Kafkova, Zuzana Somikova, Jana Kucerova, Lenka Calabkova, Pavla Luzna, Jan Stetka, Dana Simkova, Dalibor Dolezal, Vladimir Divoky
Journal: Blood (2015)
Sofosbuvir/Daclatsavir/Ribavirin for 12 Weeks in Patients with Genotype 3 Hepatitis C and Advanced Fibrosis/Cirrhosis: Results from a Real World Cohort
Authors: O.F. Ahmed, F. Marra, R. Fox, M. Priest, S. Datta, M. Heydtmann, S.T. Barclay
Journal: Journal of Hepatology (2016)
UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling
Authors: Haolong Li, Ning Xie, Ruiqi Chen, Mélanie Verreault, Ladan Fazli, Martin E. Gleave, Olivier Barbier, Xuesen Dong
Journal: Cancer Research (2016)

Castration-resistant prostate cancer (CRPC) is characterized by a shift in androgen receptor (AR) signaling from androgen-dependent to androgen (ligand)-independent. UDP-glucuronosyltransferase 2B17 (UGT2B17) is a key enzyme that maintains androgen homeostasis by catabolizing AR agonists into inactive forms. Although enhanced UGT2B17 expression by antiandrogens has been reported in androgen-dependent prostate cancer, its roles in regulating AR signaling transformation and CRPC progression remain unknown. In this study, we show that higher UGT2B17 protein expression in prostate tumors is associated with higher Gleason score, metastasis, and CRPC progression. UGT2B17 expression and activity were higher in androgen-independent compared to androgen-dependent cell lines. UGT2B17 stimulated cancer cell proliferation, invasion, and xenograft progression to CRPC after prolonged androgen deprivation. Gene microarray analysis indicated that UGT2B17 suppressed androgen-dependent AR transcriptional activity and enhanced of ligand-independent transcriptional activity at genes associated with cell mitosis. These UGT2B17 actions were mainly mediated by activation of the c-Src kinase. In CRPC tumors, UGT2B17 expression was associated positively with c-Src activation. These results indicate that UGT2B17 expedites CRPC progression by enhancing ligand-independent AR signaling to activate cell mitosis in cancer cells. Cancer Res; 76(22); 6701-11. ©2016 AACR.
VASP Protein, a Binding Partner Of BCR-ABL and FAK, May Be Implicated In The Chronic Myeloid Leukemia Phenotype
Authors: Vanessa Aline Bernusso, João Agostinho Machado-Neto, Fernando V Pericole, Karla Priscila Vieira, Adriana Silva Santos Duarte, Fabiola Traina, Marc D Hansen, Sara Teresinha Olalla Saad, Karin Spat Albino Barcellos
Journal: Blood (2013)
MRD Kinetics Can Predict the Time to Relapse after Autologous Stem Cell Transplantation (SCT) in Chronic Lymphocytic Leukemia (CLL).
Authors: Matthias Ritgen, Sebastian Boettcher, Stephan Stilgenbauer, Hartmut Dohner, Monika Brueggeman, Christine Pott, Thorsten Raff, Norbert Schmitz, Michael Hallek, Michael Kneba, Peter Dreger
Journal: Blood (2005)
P0297 : The transforming growth factor-beta (TGF-β) governs human liver tumor cell plasticity
Authors: A. Malfettone, J. Fernando, P. Koudelkova, J. Soukupova, E. Bertran, À. Fabra, M. Grubinger, B. Rani, G. Giannelli, W Mikulits, I. Fabregat
Journal: Journal of Hepatology (2015)
HCV T Cell Re-Vaccination Strategies using Simian Adeno and MVA Viral Vectors to Enhance and Maintain Anti-Viral Immunity
Authors: F. Hartnell, A. Brown, L. Swadling, A. Folgori, S. Capone, A. Nicosia, R. Cortese, S. Colloca, E. Barnes
Journal: Journal of Hepatology (2016)
Resistance Analyses for Ledipasvir/Sofosbuvir Containing Regimens in Patients Infected with Chronic HCV who Have Advanced Liver Disease or are Post Liver Transplant (Solar-1 &amp; 2 Studies)
Authors: M. Charlton, M. Manns, H. Dvory-Sobol, E. Svarovskaia, B. Doehle, S. Arterburn, C. Yun, D.M. Brainard, J.G. Mchutchison, M.D. Miller, H. Mo, N. Afdhal, D. Mutimer
Journal: Journal of Hepatology (2016)
Low Serum 25(OH) D3 Level Affects the Existence of Drug-Resistant Mutations at the NS5A Region in Patients with Chronic Hepatitis C 1b
Authors: T. Okubo, M. Atsukawa, N. Shimada, H. Abe, T. Arai, A. Nakagawa, N. Itokawa, C. Kondo, Y. Aizawa, K. Iwakiri
Journal: Journal of Hepatology (2016)